Regenxbio (RGNX) Gross Profit (QoQ) (2014 - 2025)
Regenxbio (RGNX) Gross Profit (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Regenxbio | 499.23 Mn | 269.16 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.61% |
| Sep 30, 2025 | 48.66% |
| Jun 30, 2025 | -80.68% |
| Mar 31, 2025 | 461.31% |
| Dec 31, 2024 | 26.13% |
| Sep 30, 2024 | 4.82% |
| Jun 30, 2024 | 1.86% |
| Mar 31, 2024 | 0.78% |
| Dec 31, 2023 | -33.59% |
| Sep 30, 2023 | 57.36% |
| Jun 30, 2023 | -30.11% |
| Mar 31, 2023 | -19.05% |
| Dec 31, 2022 | 38.34% |
| Sep 30, 2022 | -31.88% |
| Jun 30, 2022 | 203.00% |
| Mar 31, 2022 | -98.27% |
| Dec 31, 2021 | 2,153.40% |
| Sep 30, 2021 | 36.44% |
| Jun 30, 2021 | -12.95% |
| Mar 31, 2021 | 25.43% |